This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Neurocrine Biosciences (NBIX) reports ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

Shares of Arcus Biosciences, Inc. (RCUS) have gained 1.2% over the past four weeks to close the last trading session at $21.96, but there could still be a solid upside left in the stock if short-term ...

We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will ...

Lexaria Bioscience (NASDAQ:LEXX) was trading lower after the drug delivery platform announced a sale of 2,666,667 shares, par value $0.001 per share, at $1.50 per share in a registered direct offering ...

Harbour BioMed exercises its warrant to buy Spruce Biosciences shares, raising its stake to about 3.8% as the companies work together on the SPR202 drug program.

BD (NYSE: BDX) today set the record date for the planned spin-off of its Biosciences & Diagnostics business to Waters ...

It is being acquired for quite a meaty premium. The buyer is a top name in the global pharmaceuticals space. The purchasing party is global pharmaceutical company Novartis, which on Sunday divulged ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $45.86, with a ...

Days after starting a new investigational program, it announced four appointments to its scientific advisory board. All of these professionals are experts in the affliction being targeted. Less than ...